Quick Takeaways
- SABBY MANAGEMENT, LLC filed SCHEDULE 13G for Lyra Therapeutics, Inc. Common Stock (LYRA).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
SABBY MANAGEMENT, LLC - 31 Dec 2025 SCHEDULE 13G Report for Lyra Therapeutics, Inc. Common Stock (LYRA)
- Filing Manager
- SABBY MANAGEMENT, LLC
- Reporting Manager
- SABBY MANAGEMENT, LLC
- Security
- Lyra Therapeutics, Inc. Common Stock
- Symbol
- LYRA
- Shares outstanding
- 1,769,273 shares
- Disclosed Ownership
- 175,158 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Jan 2026, 19:18:05 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SABBY MANAGEMENT, LLC disclosed 9.9% ownership in Lyra Therapeutics, Inc. Common Stock (LYRA) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Jan 2026, 19:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | 175,158 | 0 | 175,158 | /s/ Robert Grundstein | COO | |
| Hal Mintz | 9.9% | 175,158 | 0 | 175,158 | /S/ HAL MINTZ | HAL MINTZ | |
| Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 175,158 | 0 | 175,158 | /s/ Harry Thompson | Harry Thompson |